These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
282 related articles for article (PubMed ID: 16788100)
1. Impact of chronic graft-versus-host disease on the health status of hematopoietic cell transplantation survivors: a report from the Bone Marrow Transplant Survivor Study. Fraser CJ; Bhatia S; Ness K; Carter A; Francisco L; Arora M; Parker P; Forman S; Weisdorf D; Gurney JG; Baker KS Blood; 2006 Oct; 108(8):2867-73. PubMed ID: 16788100 [TBL] [Abstract][Full Text] [Related]
2. Impact of cGVHD on socioeconomic outcomes in survivors with pediatric hematopoietic stem cell transplant in Japan: a cross-sectional observational study. Soejima T; Shiohara M; Ishida Y; Inoue M; Hayakawa A; Sato A; Kamibeppu K; Atsuta Y; Yamashita T Int J Hematol; 2021 Apr; 113(4):566-575. PubMed ID: 33386599 [TBL] [Abstract][Full Text] [Related]
3. Psychological and physical function in allogeneic hematopoietic cell transplant survivors with chronic graft-versus-host disease. Hansen JL; Juckett MB; Foster MA; Rumble ME; Morris KE; Hematti P; Costanzo ES J Cancer Surviv; 2023 Jun; 17(3):646-656. PubMed ID: 36917433 [TBL] [Abstract][Full Text] [Related]
4. Impact of chronic graft-versus-host disease on quality of life and cognitive function of long-term transplant survivors after allogeneic hematopoietic stem cell transplantation with total body irradiation. Gruber I; Koelbl O; Herr W; Holler E; Edinger M; Wolff D Radiat Oncol; 2022 Nov; 17(1):195. PubMed ID: 36447269 [TBL] [Abstract][Full Text] [Related]
5. Which questionnaires should we use to evaluate quality of life in patients with chronic graft-vs-host disease? Perić Z; Desnica L; Duraković N; Ostojić A; Pulanić D; Serventi-Seiwerth R; Prenc E; Basak G; Vrhovac R; Pavletic SZ; Nemet D Croat Med J; 2016 Feb; 57(1):6-15. PubMed ID: 26935610 [TBL] [Abstract][Full Text] [Related]
6. Oral symptom intensity, health-related quality of life, and correlative salivary cytokines in adult survivors of hematopoietic stem cell transplantation with oral chronic graft-versus-host disease. Fall-Dickson JM; Mitchell SA; Marden S; Ramsay ES; Guadagnini JP; Wu T; St John L; Pavletic SZ; Biol Blood Marrow Transplant; 2010 Jul; 16(7):948-956. PubMed ID: 20139026 [TBL] [Abstract][Full Text] [Related]
7. Severity of Chronic Graft-versus-Host Disease and Late Effects Following Allogeneic Hematopoietic Cell Transplantation for Adults with Hematologic Malignancy. Lee CJ; Wang T; Chen K; Arora M; Brazauskas R; Spellman SR; Kitko C; MacMillan ML; Pidala JA; Badawy SM; Bhatt N; Bhatt VR; DeFilipp Z; Diaz MA; Farhadfar N; Gadalla S; Hashmi S; Hematti P; Hossain NM; Inamoto Y; Lekakis LJ; Sharma A; Solomon S; Lee SJ; Couriel DR Transplant Cell Ther; 2024 Jan; 30(1):97.e1-97.e14. PubMed ID: 37844687 [TBL] [Abstract][Full Text] [Related]
8. Association of Chronic Graft-versus-Host Disease with Late Effects following Allogeneic Hematopoietic Cell Transplantation for Children with Hematologic Malignancy. Lee CJ; Wang T; Chen K; Arora M; Brazauskas R; Spellman SR; Kitko C; MacMillan ML; Pidala JA; Auletta JJ; Badawy SM; Bhatt N; Bhatt VR; Cahn JY; DeFilipp Z; Diaz MA; Farhadfar N; Gadalla S; Gale RP; Hashem H; Hashmi S; Hematti P; Hong S; Hossain NM; Inamoto Y; Lekakis LJ; Modi D; Patel S; Sharma A; Solomon S; Couriel DR Transplant Cell Ther; 2022 Oct; 28(10):712.e1-712.e8. PubMed ID: 35863740 [TBL] [Abstract][Full Text] [Related]
9. Child and parent perspectives of the chronic graft-versus-host disease (cGVHD) symptom experience: a concept elicitation study. Wiener L; Baird K; Crum C; Powers K; Carpenter P; Baker KS; MacMillan ML; Nemecek E; Lai JS; Mitchell SA; Jacobsohn DA Support Care Cancer; 2014 Feb; 22(2):295-305. PubMed ID: 24077685 [TBL] [Abstract][Full Text] [Related]
10. Physiologic Frailty in Nonelderly Hematopoietic Cell Transplantation Patients: Results From the Bone Marrow Transplant Survivor Study. Arora M; Sun CL; Ness KK; Teh JB; Wu J; Francisco L; Armenian SH; Schad A; Namdar G; Bosworth A; Kuo L; Weisdorf DJ; Forman SJ; Bhatia S JAMA Oncol; 2016 Oct; 2(10):1277-1286. PubMed ID: 27254472 [TBL] [Abstract][Full Text] [Related]
11. Content Validity of the Lee Chronic Graft-versus-Host Disease Symptom Scale as Assessed by Cognitive Interviews. Merkel EC; Mitchell SA; Lee SJ Biol Blood Marrow Transplant; 2016 Apr; 22(4):752-758. PubMed ID: 26751003 [TBL] [Abstract][Full Text] [Related]
12. Burden of morbidity in 10+ year survivors of hematopoietic cell transplantation: report from the bone marrow transplantation survivor study. Sun CL; Kersey JH; Francisco L; Armenian SH; Baker KS; Weisdorf DJ; Forman SJ; Bhatia S Biol Blood Marrow Transplant; 2013 Jul; 19(7):1073-80. PubMed ID: 23583827 [TBL] [Abstract][Full Text] [Related]
13. Patient-reported outcomes and health status associated with chronic graft- Lee SJ; Onstad L; Chow EJ; Shaw BE; Jim HSL; Syrjala KL; Baker KS; Buckley S; Flowers ME Haematologica; 2018 Sep; 103(9):1535-1541. PubMed ID: 29858386 [TBL] [Abstract][Full Text] [Related]
14. Long-Term Morbidity and Mortality in Children with Chronic Graft-versus-Host Disease Classified by National Institutes of Health Consensus Criteria after Allogeneic Hematopoietic Stem Cell Transplantation. Inagaki J; Moritake H; Nishikawa T; Hyakuna N; Okada M; Suenobu S; Nagai K; Honda Y; Shimomura M; Fukano R; Noguchi M; Kurauchi K; Tanioka S; Okamura J Biol Blood Marrow Transplant; 2015 Nov; 21(11):1973-80. PubMed ID: 26234723 [TBL] [Abstract][Full Text] [Related]
15. A prospective study of female genital chronic graft-versus-host disease symptoms, signs, diagnosis and treatment. Smith Knutsson E; Björk Y; Broman AK; Helström L; Nicklasson M; Brune M; Sundfeldt K Acta Obstet Gynecol Scand; 2018 Sep; 97(9):1122-1129. PubMed ID: 29752810 [TBL] [Abstract][Full Text] [Related]
16. Risk Factors and Outcome of Chronic Graft-versus-Host Disease after Allogeneic Stem Cell Transplantation-Results from a Single-Center Observational Study. Grube M; Holler E; Weber D; Holler B; Herr W; Wolff D Biol Blood Marrow Transplant; 2016 Oct; 22(10):1781-1791. PubMed ID: 27343720 [TBL] [Abstract][Full Text] [Related]
17. Quality of Life after Allogeneic Hematopoietic Cell Transplantation According to Affected Organ and Severity of Chronic Graft-versus-Host Disease. Kurosawa S; Oshima K; Yamaguchi T; Yanagisawa A; Fukuda T; Kanamori H; Mori T; Takahashi S; Kondo T; Kohno A; Miyamura K; Umemoto Y; Teshima T; Taniguchi S; Yamashita T; Inamoto Y; Kanda Y; Okamoto S; Atsuta Y Biol Blood Marrow Transplant; 2017 Oct; 23(10):1749-1758. PubMed ID: 28669922 [TBL] [Abstract][Full Text] [Related]
18. Late mortality after allogeneic hematopoietic cell transplantation and functional status of long-term survivors: report from the Bone Marrow Transplant Survivor Study. Bhatia S; Francisco L; Carter A; Sun CL; Baker KS; Gurney JG; McGlave PB; Nademanee A; O'Donnell M; Ramsay NK; Robison LL; Snyder D; Stein A; Forman SJ; Weisdorf DJ Blood; 2007 Nov; 110(10):3784-92. PubMed ID: 17671231 [TBL] [Abstract][Full Text] [Related]
19. Ocular Chronic Graft-versus-Host Disease and Its Relation to Other Organ Manifestations and Outcomes after Allogeneic Hematopoietic Cell Transplantation. Jeppesen H; Gjærde LK; Lindegaard J; Julian HO; Heegaard S; Sengeløv H Transplant Cell Ther; 2022 Dec; 28(12):833.e1-833.e7. PubMed ID: 36002105 [TBL] [Abstract][Full Text] [Related]
20. Donor-Recipient Matching for KIR Genotypes Reduces Chronic GVHD and Missing Inhibitory KIR Ligands Protect against Relapse after Myeloablative, HLA Matched Hematopoietic Cell Transplantation. Faridi RM; Kemp TJ; Dharmani-Khan P; Lewis V; Tripathi G; Rajalingam R; Daly A; Berka N; Storek J; Masood Khan F PLoS One; 2016; 11(6):e0158242. PubMed ID: 27341514 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]